Terns Pharmaceuticals Inc... (TERN)

3.51

-0.18 (-4.88%)

At close: Mar 03, 2025, 12:26 PM

Terns Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-90.21M	-60.34M	-50.16M	-40.57M	-68.82M	-18.02M
Depreciation & Amortization	881K	1.03M	512K	394K	195K	65K
Stock-Based Compensation	25.54M	10.77M	8.15M	1.69M	668K	234K
Other Working Capital	142K	-315K	-3.15M	6.21M	1.05M	-840K
Other Non-Cash Items	-5.03M	81K	879K	2.92M	-246K	-307K
Deferred Income Tax	141K	392K	219K	693K	206K	307K
Change in Working Capital	1.29M	-1.04M	-1.43M	5.06M	1.77M	-352K
Operating Cash Flow	-67.39M	-49.11M	-41.83M	-29.81M	-66.22M	-18.07M
Capital Expenditures	-52K	-275K	-340K	-584K	-900K	-244K
Acquisitions	n/a	22K	119.36K	-7.28K	2.96K	12.04M
Purchase of Investments	-275.78M	-139.73M	-166.3M	-715K	-58.38M	-6.95M
Sales Maturities Of Investments	237.85M	117.73M	46.94M	7.99M	55.43M	2.42M
Other Investing Acitivies	n/a	-22K	-119.36K	7.28K	-2.96K	-4.53K
Investing Cash Flow	-37.99M	-22.27M	-119.7M	6.69M	-3.86M	-4.78M
Debt Repayment	n/a	n/a	n/a	16.88M	58K	58K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.02M	-158K	-1.97M	68.64M	4K	99.7M
Financial Cash Flow	41.95M	167.5M	134.39M	85.52M	62K	99.76M
Net Cash Flow	-63.31M	95.54M	-27.16M	62.48M	-70.15M	77.02M
Free Cash Flow	-67.44M	-49.38M	-42.17M	-30.39M	-67.12M	-18.32M